Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion



Status:Enrolling by invitation
Healthy:No
Age Range:18 - Any
Updated:12/9/2018
Start Date:October 16, 2017
End Date:March 2019

Use our guide to learn which trials are right for you!

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion: A Blinded Randomized Controlled Trial

High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an
inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that
activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane
review of TENS for acute pain found inconclusive evidence. One previous abortion trial
comparing TENS to IV sedation only looked at pain control in the recovery room. The
investigators propose a randomized controlled trial comparing TENS to IV sedation (in
conjunction with local anesthesia) among women presenting for first-trimester surgical
abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during
cervical dilation.


Inclusion criteria:

- Presenting for surgical abortion

- Gestational age <12 weeks

- < 18 years of age

- Agrees to be randomized

Exclusion criteria:

- Allergy to study medications (lidocaine, fentanyl, midazolam)

- > 18 years of age

- Fetal demise

- Pre-procedure use of misoprostol

- No means of transportation following procedure
We found this trial at
1
site
San Jose, California
?
mi
from
San Jose, CA
Click here to add this to my saved trials